Immunic, Inc.

IMUX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jun 29, 2026
4 Jun 29, 2026
4 Jun 29, 2026
4 Jun 29, 2026
4 Jun 29, 2026
4 Jun 29, 2026
4 Jun 29, 2026 FORM 4
4 Jun 29, 2026
4 Jun 29, 2026
8-K Jun 29, 2026
4 Jun 1, 2026
3 Jun 1, 2026
DEF 14A May 29, 2026
8-K May 28, 2026
8-K May 27, 2026
3 May 19, 2026
8-K May 19, 2026
SCHEDULE 13G/A May 15, 2026
SCHEDULE 13G/A May 15, 2026
8-K May 13, 2026
10-Q May 13, 2026 10-Q
SCHEDULE 13G May 6, 2026
EFFECT May 4, 2026
CORRESP May 1, 2026
S-3/A Apr 30, 2026
← Newer Page 2 of 34 · 830 filings Older →